Published in Int J Oncol on February 01, 2010
Tumor suppressor function of the plasma glutathione peroxidase gpx3 in colitis-associated carcinoma. Cancer Res (2012) 1.13
p53-induced gene 3 mediates cell death induced by glutathione peroxidase 3. J Biol Chem (2012) 1.13
MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma. Mol Cancer (2011) 1.05
Loss of glutathione peroxidase 3 expression is correlated with epigenetic mechanisms in endometrial adenocarcinoma. Cancer Cell Int (2010) 1.05
Silencing of glutathione peroxidase 3 through DNA hypermethylation is associated with lymph node metastasis in gastric carcinomas. PLoS One (2012) 1.02
Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile. Infect Agent Cancer (2012) 1.01
Clinical significance and therapeutic value of glutathione peroxidase 3 (GPx3) in hepatocellular carcinoma. Oncotarget (2014) 0.97
Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression. J Ovarian Res (2011) 0.95
Promoter hypermethylation and suppression of glutathione peroxidase 3 are associated with inflammatory breast carcinogenesis. Oxid Med Cell Longev (2014) 0.87
Genetic deletion of Klf4 in the mouse intestinal epithelium ameliorates dextran sodium sulfate-induced colitis by modulating the NF-κB pathway inflammatory response. Inflamm Bowel Dis (2014) 0.86
Chaperone Hsp47 Drives Malignant Growth and Invasion by Modulating an ECM Gene Network. Cancer Res (2015) 0.85
Diagnostic value of serum glutathione peroxidase 3 levels in patients with lung cancer. Thorac Cancer (2014) 0.79
Epigenetic and Glucocorticoid Receptor-Mediated Regulation of Glutathione Peroxidase 3 in Lung Cancer Cells. Mol Cells (2016) 0.75
One-Carbon Metabolism in Prostate Cancer: The Role of Androgen Signaling. Int J Mol Sci (2016) 0.75
The Clinical Significance and Potential Therapeutic Role of GPx3 in Tumor Recurrence after Liver Transplantation. Theranostics (2016) 0.75
Tumor-stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal role of CCL7. Int J Cancer (2010) 1.16
Immunosuppressive effects of tautomycetin in vivo and in vitro via T cell-specific apoptosis induction. Proc Natl Acad Sci U S A (2002) 1.14
Sulforaphane suppresses oligomerization of TLR4 in a thiol-dependent manner. J Immunol (2009) 1.08
Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer. Gynecol Oncol (2004) 1.02
Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin. Biochem Pharmacol (2009) 1.00
Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients. Gynecol Oncol (2005) 1.00
Syndecan-2 functions as a docking receptor for pro-matrix metalloproteinase-7 in human colon cancer cells. J Biol Chem (2009) 1.00
Array comparative genomic hybridization analysis of uterine leiomyosarcoma. Gynecol Oncol (2005) 0.98
Antiproliferative effects of quercetin through cell cycle arrest and apoptosis in human breast cancer MDA-MB-453 cells. Arch Pharm Res (2008) 0.95
The use of chitosan as a condensing agent to enhance emulsion-mediated gene transfer. Biomaterials (2005) 0.95
Equol induces apoptosis through cytochrome c-mediated caspases cascade in human breast cancer MDA-MB-453 cells. Chem Biol Interact (2008) 0.94
Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation. J Cell Physiol (2009) 0.94
Neuroprotective effects of chronic hesperetin administration in mice. Arch Pharm Res (2008) 0.92
Accelerated wound healing by smad3 antisense oligonucleotides-impregnated chitosan/alginate polyelectrolyte complex. Biomaterials (2008) 0.91
Development of multiplexed bead-based immunoassays for the detection of early stage ovarian cancer using a combination of serum biomarkers. PLoS One (2012) 0.91
Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines. Gynecol Oncol (2004) 0.90
Synergistic anti-tumor effects of combination of photodynamic therapy and arsenic compound in cervical cancer cells: in vivo and in vitro studies. PLoS One (2012) 0.89
Kaempferol induced the apoptosis via cell cycle arrest in human breast cancer MDA-MB-453 cells. Nutr Res Pract (2008) 0.88
Insulin-like growth factor II mRNA-binding protein 3: a novel prognostic biomarker for oral squamous cell carcinoma. Head Neck (2011) 0.87
Analysis of molecular cytogenetic alterations in uterine leiomyosarcoma by array-based comparative genomic hybridization. J Cancer Res Clin Oncol (2012) 0.87
ras Gene mutations and expression of Ras signal transduction mediators in gastric adenocarcinomas. Arch Pathol Lab Med (2002) 0.87
Low toxicity of cationic lipid-based emulsion for gene transfer. Biomaterials (2004) 0.86
Polymerase chain reaction-based fluorescent Luminex assay to detect the presence of human papillomavirus types. Cancer Sci (2007) 0.86
Development of a bead-based multiplex genotyping method for diagnostic characterization of HPV infection. PLoS One (2012) 0.85
Differential DNA copy number aberrations in the progression of cervical lesions to invasive cervical carcinoma. Int J Oncol (2012) 0.85
Gene expression patterns in glucose-stimulated podocytes. Biochem Biophys Res Commun (2008) 0.84
Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells. Eur J Pharm Biopharm (2007) 0.83
Evaluation of a liquid bead array system for high-risk human papillomavirus detection and genotyping in comparison with Hybrid Capture II, DNA chip and sequencing methods. J Med Microbiol (2010) 0.83
Selenium enhances the efficacy of Radachlorin mediated-photodynamic therapy in TC-1 tumor development. Oncol Rep (2012) 0.82
T Cell-specific immunosuppression using tautomycetin or PTD-conjugated protein drugs. Yonsei Med J (2004) 0.81
Immunohistochemical evidence for the over-expression of Glutathione peroxidase 3 in clear cell type ovarian adenocarcinoma. Med Oncol (2010) 0.81
Multiplexed bead-based immunoassay of four serum biomarkers for diagnosis of ovarian cancer. Oncol Rep (2012) 0.81
Target-based molecular signature characteristics of cervical adenocarcinoma and squamous cell carcinoma. Int J Oncol (2013) 0.81
Expression profiling of the cellular processes in uterine leiomyomas: omic approaches and IGF-2 association with leiomyosarcomas. Cancer Res Treat (2004) 0.81
Serum selenium level in healthy Koreans. Biol Trace Elem Res (2009) 0.81
Photodynamic therapy with recombinant adenovirus AdmIL-12 enhances anti-tumour therapy efficacy in human papillomavirus 16 (E6/E7) infected tumour model. Immunology (2008) 0.80
New approaches to pathogenic gene function discovery with human squamous cell cervical carcinoma by gene ontology. Gynecol Oncol (2005) 0.80
Antiproliferative effects of dehydrocostuslactone through cell cycle arrest and apoptosis in human ovarian cancer SK-OV-3 cells. Int J Mol Med (2009) 0.80
Time-course transcriptional profiling of human amniotic fluid-derived stem cells using microarray. Cancer Res Treat (2010) 0.80
Risk prediction for malignant conversion of oral epithelial dysplasia by hypoxia related protein expression. Pathology (2013) 0.80
Angiogenic factor thymidine phosphorylase associates with angiogenesis and lymphangiogenesis in the intestinal-type gastric cancer. Pathology (2014) 0.80
Enhanced p53 gene transfer to human ovarian cancer cells using the cationic nonviral vector, DDC. Gynecol Oncol (2003) 0.79
[Comparative evaluation of ELISA and Luminex panel reactive antibody assays for HLA alloantibody screening]. Korean J Lab Med (2009) 0.79
Topical delivery of interleukin-13 antisense oligonucleotides with cationic elastic liposome for the treatment of atopic dermatitis. J Gene Med (2009) 0.79
Complement activation by sulfonated poly(ethylene glycol)-acrylate copolymers through alternative pathway. Colloids Surf B Biointerfaces (2006) 0.79
cDNA Microarray Analysis of Gene Expression Profiles Associated with Cervical Cancer. Cancer Res Treat (2003) 0.78
A novel program to design siRNAs simultaneously effective to highly variable virus genomes. Biochem Biophys Res Commun (2009) 0.78
Photogem Induces Necrosis in Various Uterine Cervical Cancer Cell Lines by PDT. Cancer Res Treat (2003) 0.77
Green tea polyphenol epigallocatechin-3 gallate (EGCG) affects gene expression of breast cancer cells transformed by the carcinogen 7,12-dimethylbenz[a]anthracene. J Nutr (2005) 0.77
Serum selenium levels in Korean hepatoma patients. Biol Trace Elem Res (2012) 0.77
The effect of adenosine 5'-triphosphate on calcium mobilization and cell proliferation in cervical cancer cells. Eur J Obstet Gynecol Reprod Biol (2006) 0.77
Therapeutic effects of systemic photodynamic therapy in a leukemia animal model using A20 cells. Lasers Med Sci (2011) 0.76
Identification of candidate biomarkers using the Experion™ automated electrophoresis system in serum samples from ovarian cancer patients. Int J Oncol (2013) 0.76
Activity of green tea polyphenol epigallocatechin-3-gallate against ovarian carcinoma cell lines. Cancer Res Treat (2004) 0.76
Comparison of As(2)O(3) and As(4)O(6) in the detection of SiHa cervical cancer cell growth inhibition pathway. Cancer Res Treat (2004) 0.75
Retraction: comparison of As2O3 and As4O6 in the detection of SiHa cervical cancer cell growth inhibition pathway. Cancer Res Treat (2007) 0.75
Synthesis of chlorin-based unsaturated fatty acid conjugates: their in vitro phototoxicity on TC-1 cancer cell line. J Photochem Photobiol B (2012) 0.75
New Approaches to Functional Process Discovery in HPV 16-Associated Cervical Cancer Cells by Gene Ontology. Cancer Res Treat (2003) 0.75
Development of bead-based immunoassay to quantify neutralizing antibody for human papillomavirus 16 and 18. Mol Biotechnol (2013) 0.75
Combination of CYP inhibitor with MEK/ERK inhibitor enhances the inhibitory effect on ERK in BRAF mutant colon cancer cells. Anticancer Res (2013) 0.75
Comparison of single-, double- and triple-combined testing, including Pap test, HPV DNA test and cervicography, as screening methods for the detection of uterine cervical cancer. Oncol Rep (2013) 0.75
Adenoviral p53 effects and cell-specific E7 protein-protein interactions of human cervical cancer cells. Biosens Bioelectron (2005) 0.75
Cell-Specific Growth Inhibition of Human Cervical Cancer Cell by Recombinant Adenovirus p53 in vitro and in vivo. Cancer Res Treat (2003) 0.75
Integrated in silico and biological validation of the blocking effect of Cot-1 DNA on Microarray-CGH. Int J Mol Med (2007) 0.75